[go: up one dir, main page]

WO2017007140A1 - Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients - Google Patents

Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients Download PDF

Info

Publication number
WO2017007140A1
WO2017007140A1 PCT/KR2016/006266 KR2016006266W WO2017007140A1 WO 2017007140 A1 WO2017007140 A1 WO 2017007140A1 KR 2016006266 W KR2016006266 W KR 2016006266W WO 2017007140 A1 WO2017007140 A1 WO 2017007140A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
periodontal disease
oral composition
preventing
periodontitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/006266
Other languages
French (fr)
Korean (ko)
Inventor
손연경
이종석
이사라
배창환
여주홍
이양구
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Republic Of Korea (ministry Of Environment National Institute Of Biological Resources)
Dong Sung Pharmaceuticals Co Ltd
Original Assignee
Republic Of Korea (ministry Of Environment National Institute Of Biological Resources)
Dong Sung Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Republic Of Korea (ministry Of Environment National Institute Of Biological Resources), Dong Sung Pharmaceuticals Co Ltd filed Critical Republic Of Korea (ministry Of Environment National Institute Of Biological Resources)
Priority to CN201680000808.7A priority Critical patent/CN106535911B/en
Publication of WO2017007140A1 publication Critical patent/WO2017007140A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/37Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Definitions

  • the present invention relates to an oral composition for the prevention and treatment of periodontal disease comprising cedar extract and arrowwood extract as an active ingredient, more specifically, the extract of cedar extract and arrowwood extract showing an excellent effect on the prevention, improvement and treatment of periodontitis It relates to an oral composition containing as a component.
  • the oral microorganisms produce toxins in the plaque, and the toxins they produce are periodontal disease when they invade the periodontal tissue and cause inflammation of the gingiva, destruction of alveolar bone, and infection, and when these bacteria produce acid, It can also be a cause.
  • microorganisms distributed in the oral cavity cause molar tooth and periodontal disease, and some of these microorganisms are known as opportunistic pathogens and have the potential to develop diseases.
  • Streptococcus mutans and Porphyromonas porphyromonas gingivalis is known to be the main pathogen causing periodontal disease.
  • Periodontitis is complicated and has a variety of symptoms.
  • One of the main causes of periodontitis is caused by microorganisms in the oral cavity. They primarily produce insoluble glucan using sugars and the like and attach to the tooth surface like various cells to form tartar. Tooth decay and periodontitis are caused by these tartars.
  • the most effective way to prevent periodontitis can be achieved by using a substance that inhibits the activity of these microorganisms and improves the blood flow of the inflamed gums.
  • proper oral cleanliness is important for the prevention of periodontitis, but a composition for oral cavity in which various drugs are formulated for the purpose of prophylactic treatment has been proposed.
  • antibiotics such as penicillin, erythromycin, and tetracycline among the drugs used for the prophylactic treatment of periodontitis are effective in inhibiting sterilization and growth, but have a large side effect such as the occurrence of resistant bacteria.
  • antimicrobial agents such as chlorhexidine have been shown to be effective in inhibiting tooth decay, but are highly toxic.
  • Korean Patent Publication No. 10-2012-0022423 composition for oral hygiene comprising the seaweed extract as an active ingredient
  • Korean Patent Publication No. 10-2008-0113504 Garnier Berry Extract as an active ingredient Containing oral bacterium inhibiting composition
  • Morus bark is Morus alba L.) or the root bark of the same plant has long been used in herbal medicine as an anti-inflammatory diuretic, laxative and antitussive expectorant.
  • the winged spindle is a deciduous shrub to the rime vine, and is distributed in Korea, Japan, Sakhalin and China. Young leaves are herbs and the wings of branches are called earheads. The leaves contain epipriedelanol, priedelin, quercetin and dulcitol. Seed oil contains saturated fatty acids (20%), oleic acid, linoleic acid, linolenic acid, capric acid and benzoic acid. Oriental medicine is used for hemostasis, gore blood, pain.
  • the present inventors have completed the present invention by confirming the efficacy using the baekbaekpi and arrowwood exhibiting the above-described efficacy in order to develop a drug exhibiting an excellent antimicrobial effect against the periodontitis causing bacteria.
  • Oral composition for preventing and treating periodontal disease or periodontal disease prevention and improvement of the health functional food of the present invention to achieve the above object including the extract of cedar and arrow extract as an active ingredient, showing the growth inhibitory activity of periodontitis-inducing bacteria Is characteristic.
  • the periodontitis causing bacteria is Porphyromonas ( Phyphyromonas) gingivalis).
  • the cedar extract and arrowwood extract is characterized by consisting of 1: 1 weight ratio.
  • the lettuce extract or arrow extract is characterized in that extracted with ethanol.
  • the oral composition is characterized by having any one or more formulations selected from toothpaste, chewing gum, mouthwash, mouthwash and mouth spray.
  • the dietary supplement is characterized by having any one or more formulations selected from powders, granules, tablets, capsules or beverages.
  • an oral composition or a health functional food which includes an extract of cedar extract and arrowwood extract as an active ingredient, and which exhibits an excellent effect on the prevention, improvement and treatment of periodontitis.
  • an extract of cedar extract and arrowwood extract as an active ingredient, and which exhibits an excellent effect on the prevention, improvement and treatment of periodontitis.
  • 1 is a graph showing the antimicrobial activity of lettuce extract.
  • Figure 2 is a graph showing the antimicrobial activity of arrowwood extract.
  • Figure 3 is a graph showing the antimicrobial activity of the mixed extract (10 ppm) consisting of cedar extract (5 ppm) + arrow extract (5 ppm).
  • Figure 4 is a graph showing the antimicrobial activity of the mixed extract (50 ppm) consisting of lettuce extract (25 ppm) + arrowwood extract (25 ppm).
  • the present invention provides an oral composition for preventing and treating periodontal disease, including the extract of cedar extract and arrowwood extract as an active ingredient.
  • the baekpipi extract or arrowwood extract is dried by extracting the baekpipi or arrowwood, respectively, 5 to 15 times the solvent of each weight (g), preferably water, lower alcohol of C1 to C4 or a mixed solvent thereof Extracts soluble in a solvent selected from, more preferably 1 to 10 times, preferably 3 to 10 hours at 10 to 50 ° C, preferably 20 to 30 ° C, preferably 3 to 36 hours with ethanol Can be obtained by repeated extraction five times.
  • the extract of the cedar extract When the extract is used as an active ingredient and the extract of the cedar extract is used as an active ingredient, the extract of the cedar extract should be contained in a high concentration in the antibacterial activity against periodontitis-inducing bacteria, the arrow extract extract has antibacterial activity even at 100ppm concentration Not shown.
  • the mixture of the lettuce extract and the arrowwood extract oral compared to conventional toothpaste.
  • the stability of the active ingredient will be able to obtain the prevention and treatment of periodontitis.
  • the extract from the cedar extract and the arrowwood extract in a 1: 1 weight ratio and use it as an active ingredient for oral composition for the prevention and treatment of periodontitis.
  • Porphyromonas gingivalis Porphyromonas gingivalis is characterized by showing antimicrobial activity.
  • the oral composition containing the extract of the present invention may be prepared by using a formulation such as toothpaste, chewing gum, mouthwash, mouthwash and mouth spray, but is not limited thereto.
  • Toothpaste of the present invention comprises a composition selected from the group consisting of abrasives, binders, moisturizers, active ingredients, foaming agents, sweeteners, flavoring agents.
  • Abrasives include aluminum hydroxide, silicic anhydride, aluminum silicate, dibasic calcium phosphate, dihydrate and anhydride, tricalcium phosphate, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate and calcium sulfate , Polymethyl methacrylate, and other synthetic resins may be used in combination of one or two or more of them in an amount of about 20-90% of the total composition (20-60% in the case of paste toothpaste).
  • synthetic polymers such as a garginine, various cellulose derivatives for thickening, gums, such as a xanthan gum and a tragacanth gum, polyvinyl alcohol, sodium polyacrylate, a polyacrylic acid / maleic acid copolymer, and carboxyvinyl polymer
  • organic binders such as derivatives
  • inorganic binders such as a silica and a laponite, 1 type, or 2 or more types can be mix
  • Paste and liquid oral compositions in dentifrices include sorbitol, glycerin, ethylene glycol, propylene glycol, polyether glycol, polypropylene glycol, and the like as moisturizing agents in the preparation of about 10-70% of the total composition. It can be used in combination.
  • oral compositions containing the extract of the present invention include menthol (Mentol), anetol (Anetol), eugenol (Eugenol), limonene (Limonene), Ocimene, n-dodecyl alcohol (n-Dodecy Alcohol, Citronenol, Alpha-Terpineol, Methyl salycilate, Methyl Acetate, Citroneryl Acetate, Cineol, Linalol, Ethyl Linalool, Vanillin, Thymol, Spearamint Oil, Sage Oil, Rosemary Oil, Cinnamon Oil, etc.
  • the agents may be used alone or in combination in amounts of 0.1-10%, preferably 0.5-5%, of the total composition.
  • sweeteners such as sodium saccharin, stevioside, aspartame, D-Xylose and the like can be used in combination in an amount of 0-1%, preferably 0.01-0.5% of the total composition.
  • oral compositions of the present invention include trichloric acid, chlorohexidine, benzetonium chloride, benzalkonium chloride, cationic fungicides such as cetylpyridium chloride, alkali metal monofluoro such as sodium monofluorophosphate and potassium monophosphate, etc.
  • Fluorides such as phosphate, sodium fluoride and tin fluoride, tranexamic acid, epsilon amino capronic acid, aluminum chlorohydroxy allantoin, dihydro cholestanol, cletylithic acid, glycerophosphate, sodium chloride, and water-soluble inorganic phosphate compounds
  • one or two or more of various potent ingredients such as ascorbic acid (sodium), dl-a-tocopherol acetate, xylitol, pyridoxine hydrochloride and polyvinyl pyrrolidone can be used in combination.
  • the surfactant used as the foaming component in the oral composition of the present invention may be used anionic surfactants, nonionic surfactants and / or zwitterionic surfactants.
  • the anionic surfactants include sodium lauryl sulfate, sodium alkyl sulfates such as myristyl sulfate, sodium N-Lauroyl sarcosinate, sodium N-miristyl sarcosinate, and the like.
  • Sodium N-acyl sarcosinate may be used
  • non-ionic surfactants include sugar-derived fatty acid esters such as sugar fatty acid esters, maltose fatty acid esters, lactose fatty acid esters, and polyesters.
  • Oxy ethylene hardened castor oil, polyoxyethylene higher alcohol ether, polyoxy ethylene polyoxy propylene copolymer, polyoxy ethylene polypropylene fatty acid ester and the like can be used.
  • Zwitterionic surfactants include N-alkyl diaminoethylglycine, such as N-lauryl di aminoethylglycine, N-myristyl diaminoethylglycine, N-alkyl-N-carboxy methyl ammonium betaine, 2-alkyl-1 -Hydroxy ethyl imidazoline betaine sodium, etc. can be used.
  • anionic surfactants are mainly used as the foaming component, and sodium alkyl sulfates such as sodium lauryl sulfate are most widely used.
  • these surfactant is used individually by 1 type or in mixture of 2 or more types, and the compounding quantity normally uses 0.01-0.5% of a whole composition, More preferably, 0.05-0.3%.
  • the present invention provides a health functional food for the prevention and improvement of periodontitis containing the extract as an active ingredient.
  • Health functional foods including the extract of the present invention can be used in a variety of drugs, foods and drinks for the prevention and improvement of periodontitis.
  • Foods to which the extract of the present invention may be added include, for example, various foods, beverages, gums, teas, vitamin complexes, health supplements, and the like, and may be used in the form of powders, granules, tablets, capsules, or beverages. have.
  • the extract itself of the present invention has little toxicity and side effects, it is a drug that can be used safely even when taken for long periods of time.
  • the extract of the present invention may be added to food or beverage for the purpose of preventing and improving periodontitis.
  • the amount of the extract in the food or beverage is generally the health food composition of the present invention can be added to 0.01 to 15% by weight of the total food weight, the health beverage composition is 0.02 to 10 g, preferably based on 100 ml It can be added at a ratio of 0.3 to 1 g.
  • the health beverage composition of the present invention in addition to containing the extract or compound as an essential ingredient in the indicated ratio, there is no particular limitation on the liquid component, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks.
  • natural carbohydrates are conventional monosaccharides such as disaccharides such as glucose and fructose, such as maltose, sucrose and the like, and polysaccharides such as dextrin, cyclodextrin and the like.
  • Sugars and sugar alcohols such as xylitol, sorbitol, and erythritol.
  • natural flavoring agents such as, tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
  • the proportion of natural carbohydrates is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.
  • the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like.
  • the health functional food of the present invention may contain natural fruit juice and fruit flesh for producing fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
  • the powder was ground in a grinder, and then 1 kg of the baekbaekpi powder was placed in 10 L of 70% ethanol and extracted under reflux for 3 hours at room temperature. The extract was repeated three times.
  • the extract was filtered to recover only the extract filtrate, and then distilled under reduced pressure to prepare a liquid extract extract (receiving concentration: 10000 ppm).
  • the prepared lettuce extract was diluted by 10 times step by step using sterile distilled water was prepared by concentration (0.1, 1, 10, 100, 1000, 10000 ppm).
  • the arrow branches were washed with purified water and then naturally dried at room temperature for 7 days.
  • the powder was ground in a grinder, and then 1 kg of the arrowwood powder was placed in 10 l of 70% ethanol, and extracted under reflux for 3 hours at room temperature. The extract was repeated three times.
  • the extract was filtered to recover only the extract filtrate and distilled under reduced pressure to prepare a liquid arrow extract (receiving concentration: 10000 ppm).
  • the manufactured arrow extract was diluted by 10 times step by step using sterile distilled water was prepared by concentration (0.1, 1, 10, 100, 1000, 10000 ppm).
  • MIC tests were performed to determine the antimicrobial activity of periodontal fungi of lettuce extract, arrow extract and mixed extracts.
  • a strain of periodontal-induced bacterium Popiromonas jinjibaris which was distributed by the ATCC American Microbial Resource Center (ATCC BAA-1703 TM ), was used.
  • Porphyromonas jinjibaris, the periodontitis-inducing bacterium gingivalis) strains were inoculated in Brain heart infusion broth medium containing 5ug / ml hemin and 1ug / ml vitamin K, and then cultured at 37 ° C.
  • the diluted solution was diluted 10 times step by step using the stock solution and sterile distilled water.
  • test tube containing the mixed solution of 1, including the bacterial culture solution, the extract and the sterilized liquid medium, was incubated at 37 ° C. for 30 hours.
  • Antibiotic determination was carried out every 3 hours of culture, 0.1 ml of the mixed solution of each treatment was measured using a 96 well palte to measure the change in absorbance due to bacterial growth at 600 nm.
  • Figure 2 is Porphyromonas jinjibaris gingivalis ) As a test for the antimicrobial activity of the arrowwood extract in the strain, it was confirmed that almost no antimicrobial activity at low concentrations of 10 ppm, 25 ppm, 50 ppm.
  • composition for preventing and treating periodontitis prepared according to the present invention when using the composition for preventing and treating periodontitis prepared according to the present invention, it is expected to exhibit excellent antimicrobial activity against the strain causing periodontitis, and to obtain the effect of preventing and treating periodontitis.
  • it can be used as a material such as, it is possible to expect an increase in added value.
  • the components belonging to a of Table 1 were added to the production unit at a temperature of 70 to 75 ° C., and stirred for 20 minutes to completely dissolve the powder and then cooled to room temperature.
  • the components belonging to b including the carrier obtained in Example 1 were added to the production unit at 25 to 30 ° C., followed by stirring for 15 minutes to dissolve.
  • the components belonging to c were mixed at 25 to 35 ° C. and added in stages.
  • the next process was a foaming agent mixing and primary degassing process, in which the components belonging to d were added to complete the primary defoaming during the 40 minute process at 25 to 35 ° C.
  • the final process is a fragrance mixing process, to which toothpaste was prepared by adding a component belonging to e and degassing at 25 to 35 ° C.
  • composition was according to Table 1 below.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral composition for preventing and treating periodontitis, comprising a mulberry root bark extract and a winged spindle extract as active ingredients and, more particularly, to an oral composition which comprises a mulberry root bark extract and a winged spindle extract as active ingredients and shows an excellent effect in the prevention, alleviation and treatment of periodontitis. The present invention provides an oral composition or a health functional food showing an excellent effect in the prevention, alleviation and treatment of periodontitis.

Description

상백피추출물과 화살나무추출물을 유효성분으로 포함하는 치주염 예방 및 치료용 구강조성물Oral composition for the prevention and treatment of periodontitis, including the extract of cedar extract and arrowwood extract

본 발명은 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 치주질환 예방 및 치료용 구강조성물에 관한 것으로서, 보다 상세하게는 치주염 예방, 개선 및 치료에 우수한 효과를 나타내는 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 구강조성물에 관한 것이다.The present invention relates to an oral composition for the prevention and treatment of periodontal disease comprising cedar extract and arrowwood extract as an active ingredient, more specifically, the extract of cedar extract and arrowwood extract showing an excellent effect on the prevention, improvement and treatment of periodontitis It relates to an oral composition containing as a component.

사람의 구강 내에는 여러 종류의 미생물들이 살고 있으며, 구강질환을 일으키는 구강미생물은 대부분 치아와 잇몸 사이에 형성되는 세균막인 프라그에 존재하는 것으로 알려져 있다.Various kinds of microorganisms live in the oral cavity of humans, and oral microorganisms causing oral diseases are known to exist in the plague, which is a bacterial membrane formed between teeth and gums.

상기 구강미생물들은 프라그에서 독소를 생성하고 이들이 생산한 독소는 치주조직 내로 침입하여 치은의 염증, 치조골의 파괴 및 감염을 일으키면 치주병이 되며, 이들 세균이 산(酸)을 생성하면, 치아우식증의 원인이 되기도 한다. The oral microorganisms produce toxins in the plaque, and the toxins they produce are periodontal disease when they invade the periodontal tissue and cause inflammation of the gingiva, destruction of alveolar bone, and infection, and when these bacteria produce acid, It can also be a cause.

이와 같이 구강 내에 분포하는 미생물들은 구치, 치주질환 등을 유발하며, 이들 미생물들의 일부는 기회성 병원체로서 질병 발병의 가능성을 가지고 있는 것으로 알려져 있다.As described above, microorganisms distributed in the oral cavity cause molar tooth and periodontal disease, and some of these microorganisms are known as opportunistic pathogens and have the potential to develop diseases.

구강 내에 상재하면서 치주질환을 발생시키는 병원성 미생물로 여러 종들이 알려져 있으나, 그 중 스트렙토코커스 뮤탄스(Streptococcus mutans)와 포피로모나스 진지바리스(Porphyromonas gingivalis)가 치주질환을 발생시키는 주 병원체인 것으로 알려져 있다.Several species are known as pathogenic microorganisms that occur in the mouth and cause periodontal disease. Among them, Streptococcus mutans and Porphyromonas porphyromonas gingivalis ) is known to be the main pathogen causing periodontal disease.

치주염은 발병요인도 복잡하고 증상도 다양하다. 이중 치주염의 주요 발생원인의 하나가 구강 내 미생물에 의한 것으로 이들은 일차적으로 당류등을 이용하여 불용성 글루칸을 생성하고 이들이 각종 균체와 같이 치아표면에 부착하여 치석을 형성하게 된다. 이러한 치석에 의해 충치 및 치주염이 발생하게 된다.Periodontitis is complicated and has a variety of symptoms. One of the main causes of periodontitis is caused by microorganisms in the oral cavity. They primarily produce insoluble glucan using sugars and the like and attach to the tooth surface like various cells to form tartar. Tooth decay and periodontitis are caused by these tartars.

따라서, 치주염을 예방하기 위한 가장 효과적인 방법은 이러한 미생물들의 활성을 억제하고, 염증이 발생한 잇몸의 혈류를 좋게하는 물질을 사용 하므로서 이루어 질 수 있다. 즉, 치주염의 예방에 대해서는 구강내 청결을 적절히 행하는 것이 중요하지만, 예방치료를 목적으로 여러 가지 약제를 배합시킨 구강용 조성물이 제안되고 있다.Therefore, the most effective way to prevent periodontitis can be achieved by using a substance that inhibits the activity of these microorganisms and improves the blood flow of the inflamed gums. In other words, proper oral cleanliness is important for the prevention of periodontitis, but a composition for oral cavity in which various drugs are formulated for the purpose of prophylactic treatment has been proposed.

특히, 치주염의 예방치료를 목적으로 사용되고 있는 약제중 페니실린, 에리스로마이신, 테트라사이클린과 같은 항생제는 살균 및 생육 억제에는 효과적이기는 하나 내성균의 출현을 유발하는 등의 부작용이 크다. 또한, 클로르헥시딘과 같은 항균제는 충치 형성을 저해하는 효과는 있으나, 독성이 강한 것으로 알려졌다.In particular, antibiotics such as penicillin, erythromycin, and tetracycline among the drugs used for the prophylactic treatment of periodontitis are effective in inhibiting sterilization and growth, but have a large side effect such as the occurrence of resistant bacteria. In addition, antimicrobial agents such as chlorhexidine have been shown to be effective in inhibiting tooth decay, but are highly toxic.

따라서, 최근에는 상기의 문제점을 해결하기 위해 종래의 구강용 세정작용 더해 약리작용 및 안정성이 우수한 구강용 조성물이 개발되고 있다.Therefore, in recent years, in order to solve the above problems, oral compositions having excellent oral pharmacological action and stability have been developed.

관련 선행기술로는 대한민국공개특허 제10-2012-0022423호 "바다제비집 추출물을 유효성분으로 포함하는 구강위생 증진용 조성물"과 대한민국공개특허 제10-2008-0113504호 "인삼열매 추출물을 유효성분으로 함유하는 구강세균 억제용 조성물" 등이 있다.Related prior art, Korean Patent Publication No. 10-2012-0022423 "composition for oral hygiene comprising the seaweed extract as an active ingredient" and Korean Patent Publication No. 10-2008-0113504 "Ginseng Berry Extract as an active ingredient Containing oral bacterium inhibiting composition ".

상백피는 뽕나무(Morus alba L.) 또는 동속식물의 뿌리껍질로서 오래전부터 소염성 이뇨제, 완화제 및 진해거담제로 한방 약제에 사용되어 왔다. Morus bark is Morus alba L.) or the root bark of the same plant has long been used in herbal medicine as an anti-inflammatory diuretic, laxative and antitussive expectorant.

최근 들어 이들 상백피에 함유된 각종 성분들이 점차 밝혀지고 그 약리 효과도 규명되고 있는데 특히 혈압 강하작용, 혈당 강하작용 및 진통 작용이 널리 알려져 있다.Recently, various ingredients contained in these baekryepi is gradually revealed and its pharmacological effects have been identified. In particular, blood pressure lowering, blood sugar lowering and analgesic are widely known.

화살나무(winged spindle)는 무환자나무목 노박덩굴과의 낙엽관목으로, 한국, 일본, 사할린, 중국 지역에 분포한다. 어린잎은 나물로 하고 가지의 날개를 귀전우(鬼剪羽)라고 한다. 잎에는 에피프리에델라놀(epifriedelanol), 프리에델린(friedelin), 퀘르세틴(quercetin), 둘시톨(dulcitol)이 함유되어있다. 종자유에는 포화지방산(20%), 올레인산, 리놀산, 리놀렌산, 카프릭산 및 안식향산 등이 함유되어 있다. 한방에서는 지혈, 구어혈, 통경에 사용한다.The winged spindle is a deciduous shrub to the rime vine, and is distributed in Korea, Japan, Sakhalin and China. Young leaves are herbs and the wings of branches are called earheads. The leaves contain epipriedelanol, priedelin, quercetin and dulcitol. Seed oil contains saturated fatty acids (20%), oleic acid, linoleic acid, linolenic acid, capric acid and benzoic acid. Oriental medicine is used for hemostasis, gore blood, pain.

이에 본 발명자들은 치주염 원인균에 대한 탁월한 항균효과를 나타내는 약물을 개발하기 위해서 상기와 같은 효능을 나타내는 상백피와 화살나무를 사용하여 그 효능을 확인함으로써 본 발명을 완성하게 되었다.Therefore, the present inventors have completed the present invention by confirming the efficacy using the baekbaekpi and arrowwood exhibiting the above-described efficacy in order to develop a drug exhibiting an excellent antimicrobial effect against the periodontitis causing bacteria.

본 발명의 목적은 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 치주질환 예방 및 치료용 구강조성물을 제공하는데 있다.It is an object of the present invention to provide an oral composition for preventing and treating periodontal disease, which comprises an extract of cedar and arrowwood as an active ingredient.

본 발명이 이루고자 하는 기술적 과제들은 이상에서 언급한 기술적 과제들로 제한되지 않으며, 언급되지 않은 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.Technical problems to be achieved by the present invention are not limited to the above-mentioned technical problems, and other technical problems not mentioned above may be clearly understood by those skilled in the art from the following description. There will be.

상기 목적을 달성하기 위한 본 발명의 치주질환 예방 및 치료용 구강조성물 또는 치주질환 예방 및 개선용 건강기능식품은 상백피추출물과 화살나무추출물을 유효성분으로 포함하여, 치주염 유발 세균의 성장 억제 활성을 나타내는 것이 특징이다.Oral composition for preventing and treating periodontal disease or periodontal disease prevention and improvement of the health functional food of the present invention to achieve the above object, including the extract of cedar and arrow extract as an active ingredient, showing the growth inhibitory activity of periodontitis-inducing bacteria Is characteristic.

상기 치주염 유발 세균은 포피로모나스 진지바리스(Porphyromonas gingivalis)인 것이 특징이다.The periodontitis causing bacteria is Porphyromonas ( Phyphyromonas) gingivalis).

상기 상백피추출물과 화살나무추출물은 1:1 중량비로 이루어지는 것이 특징이다.The cedar extract and arrowwood extract is characterized by consisting of 1: 1 weight ratio.

상기 상백피추출물 또는 화살나무추출물은 에탄올로 추출한 것이 특징이다.The lettuce extract or arrow extract is characterized in that extracted with ethanol.

상기 구강조성물은 치약류, 츄잉껌, 구강 청정제, 구강 세정제 및 구강 스프레이 중 선택된 어느 하나 이상의 제형을 갖는 것이 특징이다.The oral composition is characterized by having any one or more formulations selected from toothpaste, chewing gum, mouthwash, mouthwash and mouth spray.

상기 건강기능식품은 분말, 과립, 정제, 캡슐 또는 음료 중 선택된 어느 하나 이상의 제형을 갖는 것이 특징이다.The dietary supplement is characterized by having any one or more formulations selected from powders, granules, tablets, capsules or beverages.

본 발명에 의해, 상백피추출물과 화살나무추출물을 유효성분으로 포함하여, 치주염 예방, 개선 및 치료에 우수한 효과를 나타내는 구강조성물 또는 건강기능식품이 제공된다. 이에, 종래의 일반 치약에 비하여 구강용 약효성분의 안정성의 향상과 함께 치주염의 예방 및 치료효과를 얻을 수 있게 된다.According to the present invention, an oral composition or a health functional food is provided which includes an extract of cedar extract and arrowwood extract as an active ingredient, and which exhibits an excellent effect on the prevention, improvement and treatment of periodontitis. Thus, as compared with the conventional toothpaste, it is possible to obtain the effect of preventing or treating periodontitis with the improvement of the stability of the oral drug active ingredient.

도 1은 상백피추출물의 항균활성을 나타낸 그래프이다.1 is a graph showing the antimicrobial activity of lettuce extract.

도 2는 화살나무추출물의 항균활성을 나타낸 그래프이다.Figure 2 is a graph showing the antimicrobial activity of arrowwood extract.

도 3은 상백피추출물(5 ppm) + 화살나무추출물(5 ppm)로 이루어진 혼합추출물(10 ppm)의 항균활성을 나타낸 그래프이다.Figure 3 is a graph showing the antimicrobial activity of the mixed extract (10 ppm) consisting of cedar extract (5 ppm) + arrow extract (5 ppm).

도 4는 상백피추출물(25 ppm) + 화살나무추출물(25 ppm)로 이루어진 혼합추출물(50 ppm)의 항균활성을 나타낸 그래프이다.Figure 4 is a graph showing the antimicrobial activity of the mixed extract (50 ppm) consisting of lettuce extract (25 ppm) + arrowwood extract (25 ppm).

이하, 본 발명을 상세하게 설명하며, 본 발명의 요지를 불필요하게 흐릴 수 있는 공지 기능 및 구성에 대한 상세한 설명은 생략한다.Hereinafter, the present invention will be described in detail, and detailed descriptions of well-known functions and configurations that may unnecessarily obscure the subject matter of the present invention will be omitted.

본 발명은 상백피추출물과 화살나무추출물을 유효성분으로 포함하는 치주질환 예방 및 치료용 구강조성물을 제공한다.The present invention provides an oral composition for preventing and treating periodontal disease, including the extract of cedar extract and arrowwood extract as an active ingredient.

이때, 상기 상백피추출물 또는 화살나무추출물은 상백피 또는 화살나무를 각각 건조하여 각 무게(g)의 5~15배의 용매로 추출하며, 바람직하게는 물, C1 내지 C4의 저급알코올 또는 이들의 혼합용매로부터 선택된 용매에 가용한 추출물, 더욱 바람직하게는 에탄올로 10 내지 50℃, 바람직하게는 20 내지 30℃에서 1 내지 150 시간, 바람직하게는 3 내지 36시간으로 1 내지 10회, 바람직하게는 3 내지 5회 반복 추출하여 수득할 수 있다.At this time, the baekpipi extract or arrowwood extract is dried by extracting the baekpipi or arrowwood, respectively, 5 to 15 times the solvent of each weight (g), preferably water, lower alcohol of C1 to C4 or a mixed solvent thereof Extracts soluble in a solvent selected from, more preferably 1 to 10 times, preferably 3 to 10 hours at 10 to 50 ° C, preferably 20 to 30 ° C, preferably 3 to 36 hours with ethanol Can be obtained by repeated extraction five times.

이렇게 제조된 상기 상백피추출물과 화살나무추출물은 각각을 유효 성분으로사용할 경우에는 추출물 상에 상백피 추출물일 경우 고농도로 함유되어야 치주염 유발세균에 대한 항균활성을 나타내며, 화살나무 추출물은 100ppm 농도에서도 항균활성을 나타내지 않았다. 이에 저농도의 추출물에서도 본 발명이 목적하는 치주염 유발 세균에 대한 항균활성을 나타냄으로써 제품화 가능한 조성물을 제조하기 위해서는 상기 상백피추출물과 상기 화살나무추출물 혼합하여 사용하는 것이 좋으며, 종래의 일반 치약에 비하여 구강용 약효성분의 안정성의 향상과 함께 치주염의 예방 및 치료효과도 얻을 수 있게 되는 것이다. When the extract is used as an active ingredient and the extract of the cedar extract is used as an active ingredient, the extract of the cedar extract should be contained in a high concentration in the antibacterial activity against periodontitis-inducing bacteria, the arrow extract extract has antibacterial activity even at 100ppm concentration Not shown. In order to produce a composition that can be commercialized by showing the antimicrobial activity against the periodontitis-inducing bacteria of the present invention even at low concentrations of extracts, it is preferable to use the mixture of the lettuce extract and the arrowwood extract, oral compared to conventional toothpaste. In addition to improving the stability of the active ingredient will be able to obtain the prevention and treatment of periodontitis.

이때, 본 발명이 목적하는 치주염 유발 세균의 가장 우수한 성장 억제 활성을 얻기 위해서는 상기 상백피추출물과 상기 화살나무추출물을 1:1 중량비로 혼합하여 치주염 예방 및 치료용 구강조성물의 유효성분으로 사용하는 것이 좋으며, 치주염 유발 세균 중에서도 포피로모나스 진지바리스(Porphyromonas gingivalis)에 대하여 항균활성을 나타내는 것이 특징이다.At this time, in order to obtain the best growth inhibitory activity of the periodontitis-inducing bacteria of the present invention, it is good to use the extract from the cedar extract and the arrowwood extract in a 1: 1 weight ratio and use it as an active ingredient for oral composition for the prevention and treatment of periodontitis. Among periodontitis-causing bacteria, Porphyromonas gingivalis ) is characterized by showing antimicrobial activity.

이렇게 본 발명의 추출물을 함유하는 구강조성물은 치약류, 츄잉껌, 구강 청정제, 구강 세정제 및 구강 스프레이 등의 제형으로 제조하여 사용할 수 있으나, 이에 한정하는 것은 아니다.As described above, the oral composition containing the extract of the present invention may be prepared by using a formulation such as toothpaste, chewing gum, mouthwash, mouthwash and mouth spray, but is not limited thereto.

본 발명의 치약류는 연마제, 점결제, 보습제, 유효성분, 발포제, 감미료, 향미제로 이루어진 군에서 선택된 조성물을 포함한다.Toothpaste of the present invention comprises a composition selected from the group consisting of abrasives, binders, moisturizers, active ingredients, foaming agents, sweeteners, flavoring agents.

연마제로는 수산화알루미늄, 무수규산, 규산알루미늄, 제2인산칼슘, 제2수산화물 및 무수물, 제3인산칼슘, 탄산칼슘, 피로인산칼슘, 불용성 메타인산나트륨, 제3인산마그네슘, 탄산마그네슘, 황산칼슘, 폴리메타아크릴산메틸, 기타 합성수지 등에서 1종 또는 2종 이상을 전체 조성물의 약 20-90%의 양으로 배합하여 사용할 수있다(페이스트 치약의 경우에는 20-60%가 된다).Abrasives include aluminum hydroxide, silicic anhydride, aluminum silicate, dibasic calcium phosphate, dihydrate and anhydride, tricalcium phosphate, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate and calcium sulfate , Polymethyl methacrylate, and other synthetic resins may be used in combination of one or two or more of them in an amount of about 20-90% of the total composition (20-60% in the case of paste toothpaste).

점결제로는 가라기닌, 각종 점증용 셀룰로오스 유도체, 잔탄검, 트라가칸트 검(Tragacanth gum) 등의 검류, 폴리비닐 알콜, 폴리아크릴산 나트륨, 폴리아크릴산/말레인산 공중합체, 카르복시비닐 폴리머 등의 합성고분자 유도체 등의 유기계 점결제와 실리카, 라포나이트 등의 무기계 점결제에서 1종 또는 2종 이상을 전체 조성물의 약 0.3-5%의 양으로 배합하여 사용할 수 있다.As a caking agent, synthetic polymers, such as a garginine, various cellulose derivatives for thickening, gums, such as a xanthan gum and a tragacanth gum, polyvinyl alcohol, sodium polyacrylate, a polyacrylic acid / maleic acid copolymer, and carboxyvinyl polymer In organic binders, such as derivatives, and inorganic binders, such as a silica and a laponite, 1 type, or 2 or more types can be mix | blended in the quantity of about 0.3-5% of the whole composition.

치약류 중 페이스트상과 액상 구강용 조성물에서는 그 제조시 보습제로 솔비톨, 글리세린, 에틸렌글리콜, 프로필렌 글리콜, 폴리에테르 글리콜, 폴리프로필렌 글리콜 등에서 1종 또는 2종 이상을 전체 조성물의 약10-70%의 양으로 배합하여 사용할 수 있다.Paste and liquid oral compositions in dentifrices include sorbitol, glycerin, ethylene glycol, propylene glycol, polyether glycol, polypropylene glycol, and the like as moisturizing agents in the preparation of about 10-70% of the total composition. It can be used in combination.

한편, 본 발명의 추출물을 함유하는 구강조성물에는 맨톨(Mentol), 아네톨(Anetol), 오이게놀(Eugenol), 리모넨(Limonene), 오시멘(Ocimene), n-도데실알콜(n-Dodecy Alcohol), 시트로네놀(Citronenol), 알파터피네올(a-Terpineol), 살리실메틸(Methyl salycilate), 메틸아세테이트(Methyl Acetate), 시트로네릴 아세테이트(Citronelyl Acetate), 시네올(Cineol), 리나롤(Linalool), 에틸리나롤(Ethyl Linalool), 바닐린(Vanillin), 티몰(Thymol), 스피아민트(Speamint)유, 세지(Sage)유, 로즈마리(Rosemary)유, 계피(Cinamon)유 등의 항료를 단독 또는 조합하여 전체 조성물의 0.1-10%, 바람직하게는 0.5-5%의 양으로 배합하여 사용할 수 있다.On the other hand, oral compositions containing the extract of the present invention include menthol (Mentol), anetol (Anetol), eugenol (Eugenol), limonene (Limonene), Ocimene, n-dodecyl alcohol (n-Dodecy Alcohol, Citronenol, Alpha-Terpineol, Methyl salycilate, Methyl Acetate, Citroneryl Acetate, Cineol, Linalol, Ethyl Linalool, Vanillin, Thymol, Spearamint Oil, Sage Oil, Rosemary Oil, Cinnamon Oil, etc. The agents may be used alone or in combination in amounts of 0.1-10%, preferably 0.5-5%, of the total composition.

또한 사카린나트륨, 스테비오사이드, 아스파탐, D-자일로스(D-Xylose) 등과 같은 감미제 등을 전체 조성물의 0-1%, 바람직하게는 0.01-0.5%의 양으로 배합하여 사용할 수 있다.In addition, sweeteners such as sodium saccharin, stevioside, aspartame, D-Xylose and the like can be used in combination in an amount of 0-1%, preferably 0.01-0.5% of the total composition.

또한 본 발명의 구강조성물에는 트리클로산, 클로로 헥시딘, 벤제토늄클로라이드, 벤잘코늄크로라이드, 세틸피리듐 크리라이드과 같은 양이온성 살균제, 모노플로로인산나트륨과 모노플로로 인산칼륨 등과 같은 알카리금속 모노플로로 포스페이트와 불화나트륨, 불화제일주석 등의 불소화물, 트라넥삼산, 입실론 아미노 카프론산, 알루미늄 클로로 하이드록실 알란토인, 디하이드로 콜레스타놀, 클리틸리친산류, 글리세로 포스테이트, 염화나트륨, 수용성 무기인산 화합물, 아스코르빈산(나트륨), 초산 dl-a-토코페롤, 자일리톨, 염산피리독신, 폴리비닐 피롤리돈 등의 각종 효능성분 중 1종 또는 2종 이상을 선택 배합하여 사용할 수 있다.In addition, oral compositions of the present invention include trichloric acid, chlorohexidine, benzetonium chloride, benzalkonium chloride, cationic fungicides such as cetylpyridium chloride, alkali metal monofluoro such as sodium monofluorophosphate and potassium monophosphate, etc. Fluorides such as phosphate, sodium fluoride and tin fluoride, tranexamic acid, epsilon amino capronic acid, aluminum chlorohydroxy allantoin, dihydro cholestanol, cletylithic acid, glycerophosphate, sodium chloride, and water-soluble inorganic phosphate compounds And one or two or more of various potent ingredients such as ascorbic acid (sodium), dl-a-tocopherol acetate, xylitol, pyridoxine hydrochloride and polyvinyl pyrrolidone can be used in combination.

또한 본 발명의 구강조성물에서 발포성분으로 사용하는 계면활성제로는 음이온 계면활성제, 비이온계면활성제 및/또는 양성이온 계면활성제를 사용할 수 있다. 여기서, 음이온 계면활성제로는 라우릴황산나트륨, 미리스틸황산나트륨 등의 알킬황산나트륨, N-라우로일 사르코신산나트륨(Sodium N-Lauroyl sarcosinate), N-미리스틸 사르코신산나트륨(Sodium N-miristyl sarcosinate) 등의 N-아실 사르로신산 나트륨(Sodium N-acyl sarcosinate) 등을 사용할 수 있고, 비이온 계면활성제로는 슈가지방산 에스테르, 말토스 지방산 에스테르, 락토스 지방산 에스테르 등과 같은 당(糖)유래 지방산 에스테르, 폴리옥시 에틸렌 경화 피마자유, 폴리옥시에틸렌고급알콜 에테르, 폴리옥시 에틸렌 폴리옥시 프로필렌 공중합체, 폴리옥시 에틸렌 폴리프로필렌 지방산 에스테르 등을 사용할 수 있다. 양성이온 계면활성제로는 N-라우릴 디 아미노에틸글리신, N-미리스틸 디아미노에틸글리신 등과 같은 N-알킬 디 아미노에틸글리신, N-알킬-N-카르복시 메틸 암모늄 베타인, 2-알킬-1-하이드록시 에틸 이미다조린 베타인 나트륨 등을 사용할 수 있다. 이 경우 발포성분으로는 음이온 계면활성제를 주로 사용하며 대표적인 것으로는 라우릴 황산나트륨과 같은 알킬황산 나트륨을 가장 널리 사용하고 있다. 또한 이들 계면활성제는 1종 단독 또는 2종 이상 혼합하여 사용하며 배합량은 통상 전체 조성물의 0.01-0.5%, 보다 바람직하게는 0.05-0.3%를 사용한다.In addition, the surfactant used as the foaming component in the oral composition of the present invention may be used anionic surfactants, nonionic surfactants and / or zwitterionic surfactants. Here, the anionic surfactants include sodium lauryl sulfate, sodium alkyl sulfates such as myristyl sulfate, sodium N-Lauroyl sarcosinate, sodium N-miristyl sarcosinate, and the like. Sodium N-acyl sarcosinate may be used, and non-ionic surfactants include sugar-derived fatty acid esters such as sugar fatty acid esters, maltose fatty acid esters, lactose fatty acid esters, and polyesters. Oxy ethylene hardened castor oil, polyoxyethylene higher alcohol ether, polyoxy ethylene polyoxy propylene copolymer, polyoxy ethylene polypropylene fatty acid ester and the like can be used. Zwitterionic surfactants include N-alkyl diaminoethylglycine, such as N-lauryl di aminoethylglycine, N-myristyl diaminoethylglycine, N-alkyl-N-carboxy methyl ammonium betaine, 2-alkyl-1 -Hydroxy ethyl imidazoline betaine sodium, etc. can be used. In this case, anionic surfactants are mainly used as the foaming component, and sodium alkyl sulfates such as sodium lauryl sulfate are most widely used. Moreover, these surfactant is used individually by 1 type or in mixture of 2 or more types, and the compounding quantity normally uses 0.01-0.5% of a whole composition, More preferably, 0.05-0.3%.

또한, 본 발명은 상기 추출물을 유효성분으로 함유하는 치주염의 예방 및 개선용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for the prevention and improvement of periodontitis containing the extract as an active ingredient.

본 발명의 추출물을 포함하는 건강기능식품은 치주염의 예방 및 개선을 위한 약제, 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다.Health functional foods including the extract of the present invention can be used in a variety of drugs, foods and drinks for the prevention and improvement of periodontitis. Foods to which the extract of the present invention may be added include, for example, various foods, beverages, gums, teas, vitamin complexes, health supplements, and the like, and may be used in the form of powders, granules, tablets, capsules, or beverages. have.

본 발명의 추출물 자체는 독성 및 부작용은 거의 없으므로 예방 목적으로 장기간 복용 시에도 안심하고 사용할 수 있는 약제이다.Since the extract itself of the present invention has little toxicity and side effects, it is a drug that can be used safely even when taken for long periods of time.

이에, 본 발명의 상기 추출물은 치주염의 예방 및 개선을 목적으로 식품 또는 음료에 첨가될 수 있다. 이때, 식품 또는 음료 중의 상기 추출물의 양은 일반적으로 본 발명의 건강식품 조성물은 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물은 100 ㎖를 기준으로 0.02 내지 10 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다.Thus, the extract of the present invention may be added to food or beverage for the purpose of preventing and improving periodontitis. At this time, the amount of the extract in the food or beverage is generally the health food composition of the present invention can be added to 0.01 to 15% by weight of the total food weight, the health beverage composition is 0.02 to 10 g, preferably based on 100 ml It can be added at a ratio of 0.3 to 1 g.

본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 추출물 또는 화합물을 함유하는 것 외에 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등의 디사카라이드, 예를 들어 말토스, 슈크로스 등의 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g이다.The health beverage composition of the present invention, in addition to containing the extract or compound as an essential ingredient in the indicated ratio, there is no particular limitation on the liquid component, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks. have. Examples of the above-mentioned natural carbohydrates are conventional monosaccharides such as disaccharides such as glucose and fructose, such as maltose, sucrose and the like, and polysaccharides such as dextrin, cyclodextrin and the like. Sugars and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of natural carbohydrates is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.

상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 건강기능식품은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like. In addition, the health functional food of the present invention may contain natural fruit juice and fruit flesh for producing fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.

이하에서는 실시예 및 실험예를 들어 본 발명에 관하여 더욱 상세하게 설명할 것이나, 이들 실시예 및 실험예는 단지 설명의 목적을 위한 것으로 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but these Examples and Experimental Examples are for illustrative purposes only and are not intended to limit the protection scope of the present invention.

<실시예 1> 상백피추출물+화살나무추출물로 이루어진 혼합추출물 제조Example 1 Preparation of a Extract Extract Composed of Cedar Extract + Arrow Extract

가. 상백피추출물 제조end. Cereal Extract Extract

상백피를 정제수로 세척한 후 상온에서 7일간 자연건조하였다.After washing the baekbaekpi with purified water, it was naturally dried at room temperature for 7 days.

상기 건조 후 분쇄기로 분말화 한 다음 이 상백피 분말 1kg을 70% 에탄올 10ℓ에 넣고 상온에서 3시간 동안 환류 추출하였고, 이를 3회 반복하여 추출물을 제조하였다.After drying, the powder was ground in a grinder, and then 1 kg of the baekbaekpi powder was placed in 10 L of 70% ethanol and extracted under reflux for 3 hours at room temperature. The extract was repeated three times.

상기 추출물을 여과하여 추출 여액만을 회수한 후 감압 증류하여 액상의 상백피추출물(수령 농도: 10000 ppm)을 제조하였다. The extract was filtered to recover only the extract filtrate, and then distilled under reduced pressure to prepare a liquid extract extract (receiving concentration: 10000 ppm).

이때, 상기 제조된 상백피 추출물은 멸균 증류수를 이용하여 10배씩 단계별로 희석하여 농도별(0.1, 1, 10, 100, 1000, 10000 ppm)로 제조하였다. At this time, the prepared lettuce extract was diluted by 10 times step by step using sterile distilled water was prepared by concentration (0.1, 1, 10, 100, 1000, 10000 ppm).

나, 화살나무추출물 제조B, arrow extract manufacture

화살나무 가지를 정제수로 세척한 후 상온에서 7일간 자연건조하였다.The arrow branches were washed with purified water and then naturally dried at room temperature for 7 days.

상기 건조 후 분쇄기로 분말화 한 다음 이 화살나무 분말 1kg을 70% 에탄올 10ℓ에 넣고 상온에서 3시간동안 환류 추출하였고, 이를 3회 반복하여 추출물을 제조하였다.After drying, the powder was ground in a grinder, and then 1 kg of the arrowwood powder was placed in 10 l of 70% ethanol, and extracted under reflux for 3 hours at room temperature. The extract was repeated three times.

상기 추출물을 여과하여 추출 여액만을 회수한 후 감압 증류하여 액상의 화살나무추출물(수령 농도: 10000 ppm)을 제조하였다. The extract was filtered to recover only the extract filtrate and distilled under reduced pressure to prepare a liquid arrow extract (receiving concentration: 10000 ppm).

이때, 상기 제조된 화살나무추출물은 멸균 증류수를 이용하여 10배씩 단계별로 희석하여 농도별(0.1, 1, 10, 100, 1000, 10000 ppm)로 제조하였다. At this time, the manufactured arrow extract was diluted by 10 times step by step using sterile distilled water was prepared by concentration (0.1, 1, 10, 100, 1000, 10000 ppm).

다. 혼합추출물 제조All. Mixed Extract Preparation

상기 가. 에서 제조된 상백피 추출물과 상기 나. 에서 제조된 화살나무추출물을 같은 농도별로 준비한 후 1:1 중량비로 혼합한 혼합추출물을 제조하였다. Above a. The extract of baekbaekpi prepared in the above b. Prepared by the same concentration of arrowwood extract prepared in the mixed extract was prepared in a 1: 1 weight ratio.

<실험예 1> 항균활성 확인Experimental Example 1 Antibacterial Activity

상백피추출물과 화살나무추출물 그리고 이들의 혼합추출물의 치주염균에 대한 항균활성을 측정하기 위하여 MIC(mininal inhibitory concentration) 테스트를 진행하였다.Minic inhibitory concentration (MIC) tests were performed to determine the antimicrobial activity of periodontal fungi of lettuce extract, arrow extract and mixed extracts.

1. 시험 대상 균주1. Strains to be tested

사용된 균주는 ATCC 미국미생물자원센터(American type Culture Collection, ATCC BAA-1703TM)에서 분양받은 치주염유발세균인 포피로모나스 진지바리스 균주를 사용하였다.As the strain used, a strain of periodontal-induced bacterium Popiromonas jinjibaris, which was distributed by the ATCC American Microbial Resource Center (ATCC BAA-1703 ), was used.

2. 시험방법2. Test method

1) 균주 배양 조건1) Strain Culture Conditions

상기 분양받은 치주염유발세균인 포피로모나스 진지바리스(Porphyromonas gingivalis) 균주를 5ug/ml hemin과 1ug/ml vitamin K를 포함하는 Brain heart infusion broth 배지에 접종한 후 이를 37℃에서 정치배양하였다. Porphyromonas jinjibaris, the periodontitis-inducing bacterium gingivalis) strains were inoculated in Brain heart infusion broth medium containing 5ug / ml hemin and 1ug / ml vitamin K, and then cultured at 37 ° C.

2) 추출물의 처리2) Treatment of Extract

① 최종 혼합액이 1 ㎖이 되도록, 멸균된 액체 배지 0.9 ㎖, 각 농도에 따른 추출물 0.1 ㎖ (10%, V/V), 107 cfu/㎖ 농도의 세균 배양액 1 ㎖를 시험관에 혼합하여 혼합액을 제조하였다. ① Mix the mixed solution by mixing 0.9 ml of sterilized liquid medium, 0.1 ml (10%, V / V), and 1 ml of bacterial culture solution at a concentration of 10 7 cfu / ml so that the final mixture is 1 ml. Prepared.

② 추출물의 경우 원액과 멸균 증류수를 이용하여 10배씩 단계별로 희석한 희석액을 처리하도록 하였다.② For extract, the diluted solution was diluted 10 times step by step using the stock solution and sterile distilled water.

③ 상백피 추출물과 화살나무추출물의 혼합 처리구는 각 추출물을 0.05 ㎖씩 넣어주며, 추출물을 처리하지 않는 경우는 0.1 ㎖의 멸균 증류수를 처리하도록 하였다.③ Mixture treatment of baekbaekpi extract and arrowwood extract put each extract 0.05 ㎖, if the extract is not treated 0.1 sterile distilled water to be treated.

3) 배양방법3) Culture method

세균 배양액, 추출물, 멸균된 액체 배지를 포함하는 상기 ①의 혼합액이 담긴 시험관을 37℃에서 30 시간 배양하였다.The test tube containing the mixed solution of ①, including the bacterial culture solution, the extract and the sterilized liquid medium, was incubated at 37 ° C. for 30 hours.

항생활성의 판정은 배양 3시간 마다 각 처리구의 혼합액 0.1 ㎖를 취하여 96 well palte를 이용 세균 증식에 의한 흡광도 변화를 600 nm에서 측정하였다.Antibiotic determination was carried out every 3 hours of culture, 0.1 ml of the mixed solution of each treatment was measured using a 96 well palte to measure the change in absorbance due to bacterial growth at 600 nm.

2. 실험결과2. Experimental Results

1) 상백피 추출물의 항균활성1) Antimicrobial Activity of Extracts

도 1은 포피로모나스 진지바리스(Porphyromonas gingivalis) 균주를 대상으로 상백피 추출물의 항균활성을 시험한 것으로서, 저농도인 10 ppm에서는 항균활성이 거의 나타나지 않으며, 25 ppm에서도 항균활성이 다소 약하게 나타남을 확인하였다.1 is Porphyromonas gingivalis ) As a test for the antimicrobial activity of the extracts from the extracts of the lettuce, it was confirmed that the antimicrobial activity was almost absent at low concentrations of 10 ppm, and slightly weaker at 25 ppm.

2) 화살나무 추출물의 항균활성2) Antimicrobial Activity of Arrowwood Extract

도 2는 포피로모나스 진지바리스(Porphyromonas gingivalis) 균주를 대상으로 화살나무 추출물의 항균활성을 시험한 것으로서, 저농도인 10 ppm, 25 ppm, 50 ppm 모두에서 항균활성이 거의 나타나지 않음을 확인하였다.Figure 2 is Porphyromonas jinjibaris gingivalis ) As a test for the antimicrobial activity of the arrowwood extract in the strain, it was confirmed that almost no antimicrobial activity at low concentrations of 10 ppm, 25 ppm, 50 ppm.

3) 상백피추출물+화살나무추출물로 이루어진 혼합추출물의 항균활성3) Antimicrobial Activity of Mixed Extract Composed of Morus Extract + Arrow Extract

도 3 및 4는 포피로모나스 진지바리스(Porphyromonas gingivalis) 균주를 대상으로 상백피추출물+화살나무추출물로 이루어진 혼합추출물의 항균활성을 시험한 것으로서, 혼합추출물을 10 ppm(도 3)과 혼합추출물을 50 ppm(도 4) 처리시 항균활성을 확인하였다. 3 and 4 in the foreskin Monastir seriously Baris (Porphyromonas gingivalis ) As a test for the antimicrobial activity of the mixed extract consisting of lettuce extract + arrowroot extract against the strain, 10 ppm (Fig. 3) and 50 ppm (Fig. 4) of the mixed extract was confirmed the antimicrobial activity. .

도 3에 나타나 있듯이, 저농도인 화살나무추출물 5 ppm을 단독처리한 경우(-■-) 거의 활성을 나타내지 못하였고, 상백피추출물 5 ppm을 단독처리한 경우(-▲-)에도 거의 활성을 나타내지 못하였다. 또한 본 발명의 유효성분인 1:1 혼합추출액 10 ppm(상백피추출물과 화살나무추출물 각 5 ppm, 실시예 1)의 경우도 항균활성을 거의 나타내지 못함을 확인하였다(-◆-). As shown in FIG. 3, low activity of 5 ppm of arrowwood extract (-■-) showed little activity, and almost no activity of 5 ppm of cedar extract (-▲-). It was. In addition, it was confirmed that the active ingredient of the present invention 1: 1 mixed extract 10 ppm (5 ppm each of the fungus extract and arrowwood extract, Example 1) showed almost no antibacterial activity (-◆-).

도 4에 나타나 있듯이, 화살나무추출물 25 ppm 단독처리한 경우 (-■-) 거의 활성을 나타내지 못하였고, 상백피추출물 25 ppm 단독처리한 경우 (-▲-)의 경우에는 항균 활성을 미비하게 보이기는 하나, 본 발명이 목적하는 항균 활성능에 미치지 못하는 반면, 본 발명의 유효성분인 1:1 혼합추출액 50 ppm(상백피추출물과 화살나무추출물 각 25 ppm, 실시예 1)의 경우에는 치주염유발세균인 포피로모나스 진지바리스(Porphyromonas gingivalis)에 대해 강력한 억제활성을 나타내는 바, 본 발명의 유효성분인 1:1 혼합추출액(상백피추출물과 화살나무추출물 각 25 ppm, 실시예 1)이 단독처리 추출물보다 항균활성에 대하여 상승효과가 있는 것으로 판단되었다(-◆-). As shown in Figure 4, when treated with 25 ppm alone arrow extract (-■-) showed almost no activity, and when treated with 25 ppm single leaf extract (-▲-) showed a poor antimicrobial activity However, while the present invention does not reach the desired antimicrobial activity, in the case of 50 ppm (25 ppm each of cedar extract and arrowwood extract, Example 1), which is an active ingredient of the present invention, in the case of periodontitis-inducing bacteria As a potent inhibitory activity against Porphyromonas gingivalis ( Porphyromonas gingivalis ), 1: 1 mixed extract (25 ppm each of the extracts of cedar and arrowwood extract, Example 1), which is an active ingredient of the present invention, was more antibacterial than a single extract. It was judged to have a synergistic effect on activity (-◆-).

따라서, 본 발명에 의하여 제조된 치주염 예방 및 치료용 조성물을 이용할 경우, 치주염을 일으키는 균주에 대해 우수한 항균활성을 나타내어, 치주염 예방 및 치료효과를 얻을 수 있게 될 것으로 사료되며, 이로 인해 건강식품, 의약품 등의 소재로 사용이 가능해짐에 따라 부가가치의 상승도 기대할 수 있게 된다.Therefore, when using the composition for preventing and treating periodontitis prepared according to the present invention, it is expected to exhibit excellent antimicrobial activity against the strain causing periodontitis, and to obtain the effect of preventing and treating periodontitis. As it can be used as a material such as, it is possible to expect an increase in added value.

<제제예 1: 치약 제조><Example 1: Preparation of toothpaste>

하기 표 1의 a에 속하는 성분들을 70 내지 75℃의 온도로 제조부에 투입한 후 20분간 교반하여 분체를 완전히 용해한 뒤 상온으로 냉각하였다. The components belonging to a of Table 1 were added to the production unit at a temperature of 70 to 75 ° C., and stirred for 20 minutes to completely dissolve the powder and then cooled to room temperature.

이어서 보습제, 감미료 및 유용성분의 용해 공정으로서, 상기 실시예 1에서 얻어진 담체를 포함하는 b에 속하는 성분들을 25 내지 30℃로 제조부에 투입한 후 15분간 교반 혼합하여 용해하였다. Subsequently, as a dissolution process of the moisturizer, sweetener and useful components, the components belonging to b including the carrier obtained in Example 1 were added to the production unit at 25 to 30 ° C., followed by stirring for 15 minutes to dissolve.

다음은 분체 및 점성제 혼합공정으로서, c에 속하는 성분들을 25 내지 35℃에서 혼합해서 단계적으로 투입하였다. 다음 공정은 기포제 혼합 및 1차 탈포 공정으로서, d에 속하는 성분을 첨가하여 25 내지 35℃에서 40분간의 공정 동안에 1차 탈포를 완료하였다. 마지막 공정은 향 혼합공정으로서, e에 속하는 성분을 첨가하고 25 내지 35℃에서 2차 탈포하여 치약을 제조하였다. Next, as a powder and viscous mixing process, the components belonging to c were mixed at 25 to 35 ° C. and added in stages. The next process was a foaming agent mixing and primary degassing process, in which the components belonging to d were added to complete the primary defoaming during the 40 minute process at 25 to 35 ° C. The final process is a fragrance mixing process, to which toothpaste was prepared by adding a component belonging to e and degassing at 25 to 35 ° C.

그 조성물은 다음의 표 1에 준하였다.The composition was according to Table 1 below.

배합목적Purpose of Mixing 성분명Ingredient Name 규격standard 분량amount 단위unit 비고Remarks 용제solvent 정제수Purified water 약전pharmacopoeia 적량Quantity aa 기제Mechanism 디소르비톨액Dissorbitol solution 약전pharmacopoeia 33.0033.00 gg 기제Mechanism 프로필렌글리콜Propylene glycol 식첨Food 5.105.10 gg 기제Mechanism 농글리세린Concentrated glycerin 약전pharmacopoeia 8.258.25 gg 주성분chief ingredient 침강탄산칼슘Precipitated Calcium Carbonate 약전pharmacopoeia 30.0030.00 gg bb 주성분chief ingredient 아미노산카프론산Amino acid capronic acid 약전pharmacopoeia 0.010.01 gg 주성분chief ingredient 인산일수소칼슘Calcium dihydrogen phosphate 약전pharmacopoeia 0.010.01 gg 점증제Thickener 이산화규소Silicon dioxide 식첨Food 18.8418.84 gg 방부제antiseptic 안식향산나트륨Sodium benzoate 식첨Food 0.180.18 gg 감미제Sweetener 녹차추출물Green Tea Extract 약전pharmacopoeia 0.010.01 gg 감미제Sweetener 삭카린나트륨Zaccarin Sodium 식첨Food 0.010.01 gg 감미제Sweetener 자일리톨Xylitol 식첨Food 0.010.01 gg 감미제Sweetener 키토산Chitosan 식첨Food 0.010.01 gg 감미제Sweetener 프로폴리스추출물Propolis Extract 별규Annex 0.010.01 gg 감미제Sweetener 실시예1의혼합추출물Mixture Extract of Example 1 0.010.01 gg 기제Mechanism 폴리에칠렌글리콜 1500Polyethylene glycol 1500 약전pharmacopoeia 0.480.48 gg cc 점도조절제Viscosity Modifier 카르복시메칠셀룰로오스나트륨Carboxymethyl Cellulose Sodium 식첨Food 0.720.72 gg 기포제Foam 라우릴황산나트륨Sodium Lauryl Sulfate 약전pharmacopoeia 2.442.44 gg dd 착향제Flavor DL-멘톨DL-menthol 식첨Food 적량Quantity gg 착향제Flavor 페파민트Peppermint 비,피Rain, blood 적량Quantity gg ee 합계100g으로 맞춤100g total

상기의 본 발명은 바람직한 실시예를 중심으로 살펴보았으며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자는 본 발명의 본질적 기술 범위 내에서 상기 본 발명의 상세한 설명과 다른 형태의 실시 예들을 구현할 수 있을 것이다. 여기서 본 발명의 본질적 기술범위는 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to preferred embodiments, and those skilled in the art to which the present invention pertains to the detailed description of the present invention and other forms of embodiments within the essential technical scope of the present invention. Could be. Here, the essential technical scope of the present invention is shown in the claims, and all differences within the equivalent range will be construed as being included in the present invention.

Claims (12)

상백피추출물과 화살나무추출물을 유효성분으로 포함하여,Including cedar extract and arrow extract as active ingredients, 치주염 원인균의 성장 억제 활성을 나타내는 것이 특징인,Characterized by showing the growth inhibitory activity of periodontal causative bacteria, 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 제 1항에 있어서, The method of claim 1, 상기 치주염 원인균은 포피로모나스 진지바리스(Porphyromonas gingivalis)인 것을 특징으로 하는, The periodontitis causing bacteria is porphyromonas jinjibaris ( Porphyromonas gingivalis ), characterized in that 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 제 1항에 있어서,The method of claim 1, 상기 상백피추출물과 화살나무추출물은 1:1 중량비로 이루어지는 것이 특징인,The cedar extract and the arrowwood extract is characterized in that the weight ratio of 1: 1, 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 제 1항에 있어서, The method of claim 1, 상기 상백피추출물은 에탄올로 추출하는 것을 특징으로 하는, The extract extract is characterized in that extracted with ethanol, 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 제 1항에 있어서, The method of claim 1, 상기 화살나무추출물은 에탄올로 추출하는 것을 특징으로 하는, The arrow extract is characterized in that extracted with ethanol, 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 제 1항에 있어서,The method of claim 1, 상기 구강조성물은 치약류, 츄잉껌, 구강 청정제, 구강 세정제 및 구강 스프레이 중 선택된 어느 하나 이상의 제형을 갖는 것을 특징으로 하는,The oral composition is characterized in that it has any one or more formulations selected from toothpaste, chewing gum, mouthwash, mouthwash and mouth spray, 치주질환 예방 및 치료용 구강조성물.Oral composition for preventing and treating periodontal disease. 상백피추출물과 화살나무추출물을 유효성분으로 포함하는,It contains cedar extract and arrow extract as an active ingredient, 치주염 유발 세균의 성장 억제 활성을 나타내는 것이 특징인,Characterized by showing the growth inhibitory activity of periodontitis-inducing bacteria, 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease. 제7항에 있어서, The method of claim 7, wherein 상기 치주염 유발 세균은 포피로모나스 진지바리스(Porphyromonas gingivalis) 인 것을 특징으로 하는, The periodontitis causing bacteria is characterized in that Porphyromonas gingivalis ( Porphyromonas gingivalis ), 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease. 제7항에 있어서,The method of claim 7, wherein 상기 상백피추출물과 화살나무추출물은 1:1 중량비로 이루어지는 것이 특징인,The cedar extract and the arrowwood extract is characterized in that the weight ratio of 1: 1, 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease. 제7항에 있어서, The method of claim 7, wherein 상기 상백피추출물은 에탄올로 추출하는 것을 특징으로 하는, The extract extract is characterized in that extracted with ethanol, 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease. 제7항에 있어서, The method of claim 7, wherein 상기 화살나무추출물은 에탄올로 추출하는 것을 특징으로 하는, The arrow extract is characterized in that extracted with ethanol, 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease. 제 1항에 있어서,The method of claim 1, 상기 건강기능식품은 분말, 과립, 정제, 캡슐 또는 음류 중 선택된 어느 하나 이상의 제형을 갖는 것을 특징으로 하는,The health functional food is characterized in that it has any one or more formulations selected from powders, granules, tablets, capsules or beverages, 치주질환 예방 및 개선용 건강기능식품.Health functional food for prevention and improvement of periodontal disease.
PCT/KR2016/006266 2015-07-08 2016-06-13 Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients Ceased WO2017007140A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201680000808.7A CN106535911B (en) 2015-07-08 2016-06-13 Oral composition for periodontitis prevention and treatment containing Morus alba extract and Euonymus extract as active ingredients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150096890A KR101641213B1 (en) 2015-07-08 2015-07-08 Oral composition comprising Morus alba L. extract and Winged spindle extract for preventing and treating periodontal disease
KR10-2015-0096890 2015-07-08

Publications (1)

Publication Number Publication Date
WO2017007140A1 true WO2017007140A1 (en) 2017-01-12

Family

ID=56680280

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/006266 Ceased WO2017007140A1 (en) 2015-07-08 2016-06-13 Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients

Country Status (3)

Country Link
KR (1) KR101641213B1 (en)
CN (1) CN106535911B (en)
WO (1) WO2017007140A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022006B1 (en) 2017-09-07 2019-09-18 태이생명과학 주식회사 Composition for Preventing or Treating Periodontal Disease Comprising Scutellaria Extract treated by Enzyme Isolated from Aspergillus niger as Active Ingredient
KR20190058127A (en) 2017-11-21 2019-05-29 동의대학교 산학협력단 Compositions for the prevention or treatment of oral diseases, including extracts of acer tegmentosum maxim extract
KR102097387B1 (en) 2018-05-04 2020-04-06 원광대학교산학협력단 A composition for preventing and treating oral disease comprising black rice
KR102166701B1 (en) 2018-06-18 2020-10-16 스노우화이트팩토리(주) Composition for Preventing or Treating Periodontal Disease Comprising Scutellaria Extract treated by Aspergillus niger as Active Ingredient
KR20210133852A (en) * 2020-04-29 2021-11-08 한국 한의학 연구원 Composition for preventing, improving or treating bone disease comprising Euonymus alatus extract as effective component

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020082308A (en) * 2001-04-20 2002-10-31 강중열 Composition for the mouth containing extraction of Euonymus alatus Sieb
KR20020087225A (en) * 2001-05-14 2002-11-22 (주)바이오케어 Antibacterial agent for oral pathogens
KR20110131498A (en) * 2010-05-31 2011-12-07 김선일 An antimicrobial agent comprising silver ions in an alkaline solution extracted from shells or shellfish lakes and a composition comprising the same.
JP2014111652A (en) * 2014-02-28 2014-06-19 Lotte Co Ltd Methioninase inhibitor and composition for oral cavity and food and drink containing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101641215B1 (en) * 2015-05-15 2016-07-20 대한민국(환경부 국립생물자원관장) Oral composition comprising Morus alba L. extract and Winged spindle extract for preventing and treating dental caries

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020082308A (en) * 2001-04-20 2002-10-31 강중열 Composition for the mouth containing extraction of Euonymus alatus Sieb
KR20020087225A (en) * 2001-05-14 2002-11-22 (주)바이오케어 Antibacterial agent for oral pathogens
KR20110131498A (en) * 2010-05-31 2011-12-07 김선일 An antimicrobial agent comprising silver ions in an alkaline solution extracted from shells or shellfish lakes and a composition comprising the same.
JP2014111652A (en) * 2014-02-28 2014-06-19 Lotte Co Ltd Methioninase inhibitor and composition for oral cavity and food and drink containing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PARK, K. M. ET AL.: "Kuwanon G: an Antibacterial Agent from the Root Bark of Morus Alba against Oral Pathogens", JOURNAL OF ETHNOPHARMACOLOGY, vol. 84, no. 2-3, 2003, pages 181 - 185, XP055035527 *

Also Published As

Publication number Publication date
CN106535911A (en) 2017-03-22
CN106535911B (en) 2020-05-05
KR101641213B1 (en) 2016-07-20

Similar Documents

Publication Publication Date Title
WO2017007140A1 (en) Oral composition for preventing and treating periodontitis, comprising mulberry root bark extract and winged spindle extract as active ingredients
KR101394832B1 (en) Compositions with antibacterial effect on oral bacteria containing extracts of ginseng fruits
KR101450098B1 (en) Composition for cleaning oral cavity containing fucoidan
WO2016186335A2 (en) Oral composition for cavity prevention and treatment including mulberry root extract and euonymus alatus extract as effective ingredients
KR102408893B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR101202302B1 (en) Composition for treating and preventing periodontal disease and caries comprising bee venom
JPH08175945A (en) Oral composition
JP3008525B2 (en) Oral composition
KR102636026B1 (en) Composition for prevention or trreatment of dental disease comprising an extract of Thalictrum aquilegiifolium
WO2017086653A1 (en) Oral composition and method for preparing same
KR20170114187A (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR20170103476A (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
KR102231892B1 (en) Composition for prevention or treatment of dental disease comprising an extract of Astilbe chinesis
KR20020082308A (en) Composition for the mouth containing extraction of Euonymus alatus Sieb
KR102415612B1 (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR102260939B1 (en) Composition for prevention or treatment of dental disease comprising an extract of Matteuccia struthiopteris
KR102417082B1 (en) Composition for prevention or treatment of oral disease comprising Celosia argentea Extract
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR20220019489A (en) Composition for oral cavity containing herbal extracts
KR20170120399A (en) Composition for prevention or treatment of oral disease comprising Genistein
KR20220019490A (en) Composition for oral cavity containing herbal extracts
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR20170120411A (en) Composition for prevention or treatment of oral disease comprising Scopoletin
KR20170134123A (en) Composition for prevention or treatment of dental disease comprising astragaloside
KR20090072848A (en) Composition for prevention and treatment of tooth decay, containing ginseng extract as an active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16821546

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16821546

Country of ref document: EP

Kind code of ref document: A1